Literature DB >> 15865436

Green fluorescent protein-expressing Escherichia coli as a selective probe for HOCl generation within neutrophils.

Amy M Palazzolo1, Christine Suquet, Michael E Konkel, James K Hurst.   

Abstract

Escherichia coli were transformed by electroporation to introduce a plasmid harboring a GFP gene-containing vector. The fluorescence of the purified GFP isolated from the transformant was quenched by myeloperoxidase (MPO)-generated HOCl, by peroxynitrous acid (ONOOH) and by enzymatically or radiolytically generated NO(2)(.) but not by other putative neutrophil-generated oxidants. Fluorescence from the bacterium was effectively quenched by HOCl but not peroxynitrite, oxidizing radicals derived from its O-O bond homolysis, or the other oxidants under study. Exposure of serum-opsonized bacteria to human neutrophils resulted in extensive loss of GFP fluorescence; fluorescence microscopy revealed that phagocytosed bacteria were completely quenched but that bacteria remaining in the external media were unquenched. Addition of sodium azide to the medium to inhibit MPO prevented neutrophil-mediated fluorescence quenching. Because the amount of HOCl required to inhibit bacterial fluorescence was an order of magnitude greater than required to inhibit colonial growth, these results imply that sufficient HOCl was formed within the neutrophil phagosome to kill the microbe.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15865436     DOI: 10.1021/bi047342s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Myeloperoxidase in human neutrophil host defence.

Authors:  William M Nauseef
Journal:  Cell Microbiol       Date:  2014-06-19       Impact factor: 3.715

Review 2.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

3.  Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis.

Authors:  Nina Dickerhof; Vivienne Isles; Philip Pattemore; Mark B Hampton; Anthony J Kettle
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

4.  Biological Trojan horse: Antigen 43 provides specific bacterial uptake and survival in human neutrophils.

Authors:  Sara Fexby; Thomas Bjarnsholt; Peter Østrup Jensen; Viktoria Roos; Niels Høiby; Michael Givskov; Per Klemm
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

5.  Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2.

Authors:  Haowei Song; Shunzhong Bao; Sasanka Ramanadham; John Turk
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

6.  Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria.

Authors:  Jamie Schwartz; Kevin G Leidal; Jon K Femling; Jerrold P Weiss; William M Nauseef
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

Review 7.  The role of nitrite ion in phagocyte function--perspectives and puzzles.

Authors:  Jonathan L Cape; James K Hurst
Journal:  Arch Biochem Biophys       Date:  2009-04-15       Impact factor: 4.013

8.  Comparative study of HOCl-inflicted damage to bacterial DNA ex vivo and within cells.

Authors:  Christine Suquet; Jeffrey J Warren; Nimulrith Seth; James K Hurst
Journal:  Arch Biochem Biophys       Date:  2009-10-20       Impact factor: 4.013

9.  Pathways for intracellular generation of oxidants and tyrosine nitration by a macrophage cell line.

Authors:  Amy M Palazzolo-Ballance; Christine Suquet; James K Hurst
Journal:  Biochemistry       Date:  2007-05-27       Impact factor: 3.162

10.  Pivotal Advance: Pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish.

Authors:  Catherine A Loynes; Jane S Martin; Anne Robertson; Daniel M I Trushell; Philip W Ingham; Moira K B Whyte; Stephen A Renshaw
Journal:  J Leukoc Biol       Date:  2010-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.